N-(2-Dimethylaminoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 5g

2-(2-Fluorophenyl)-2-methylpropionic acid, 95.0%, 25g

Ultrasonic device series-H, 2.6 l, H 30 1 Piece

Ethyl 4-methylpiperidine-4-carboxylate hydrochloride, 95.0%, 5g

2-Bromothiophene-5-boronic acid, 97.0%, 5g

3-(4-Nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 95.0%, 250mg

C8-Alkyne-dU-CEP, ≥95%, 250 mg, plastic packaging.

3'-(Trifluoromethoxy)acetophenone>97.0%(GC)5g

2-Bromo-5-fluorobenzoic acid, 98.0%, 25g

(S)-N-((3-(3-Fluoro-4-(4-(2-hydroxyacetyl)piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 95.00%, 25mg

[2,2'-Bipyridine]-6,6'-dicarbaldehyde, 95%, 250mg

4-(Aminomethyl)-N-methylbenzamide, 95.0%, 1g

5-Chloro-8-nitroquinoline, 95.0%, 2.5g